A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of [14C] BMS-986369 in Healthy Male Participants
Latest Information Update: 20 Feb 2023
At a glance
- Drugs Golcadomide (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 16 Feb 2023 Status changed from recruiting to completed.
- 07 Nov 2022 Status changed from not yet recruiting to recruiting.
- 07 Oct 2022 New trial record